Trinity Capital Inc. Expands Life Sciences Vertical with Appointment of Paul D'Agrosa
Trinity Capital (Nasdaq: TRIN) appointed Paul D'Agrosa as Managing Director of Life Sciences, based in Denver, effective Oct. 8, 2025.
Mr. D'Agrosa joins to help expand Trinity's Life Sciences platform across new U.S. markets; he brings more than a decade of experience in loan origination, business development, and relationship management. His prior roles include Managing Director at Horizon Technology Finance, where he helped originate more than $140 million in new loan commitments within his first 15 months, and 10 years at Silicon Valley Bank in relationship and credit roles.
The company framed the hire as a step to strengthen life‑sciences lending and source new opportunities across Medtech, Healthtech, Biotech, and Diagnostics/Tools.
Trinity Capital (Nasdaq: TRIN) ha nominato Paul D'Agrosa come Managing Director delle Life Sciences, con sede a Denver, con effetto dall'8 ottobre 2025.
Il signor D'Agrosa si è unito per espandere la piattaforma Life Sciences di Trinity sui nuovi mercati statunitensi; porta con sé oltre un decennio di esperienza in origination di prestiti, sviluppo commerciale e gestione delle relazioni. I suoi incarichi precedenti includono Managing Director presso Horizon Technology Finance, dove ha contribuito a originaire più di 140 milioni di dollari in nuovi impegni di prestito nei suoi primi 15 mesi, e 10 anni in Silicon Valley Bank in ruoli legati alle relazioni e al credito.
L'azienda ha inquadrato questa assunzione come un passo per rafforzare il credito nel settore Life Sciences e per individuare nuove opportunità nei settori Medtech, Healthtech, Biotech e Diagnostics/Tools.
Trinity Capital (Nasdaq: TRIN) ha nombrado a Paul D'Agrosa como Managing Director de Life Sciences, con sede en Denver, con efecto a partir del 8 de octubre de 2025.
El Sr. D'Agrosa se une para expandir la plataforma de Life Sciences de Trinity en nuevos mercados de EE. UU.; aporta más de una década de experiencia en originación de préstamos, desarrollo de negocios y gestión de relaciones. Sus roles anteriores incluyen Managing Director en Horizon Technology Finance, donde ayudó a originar más de 140 millones de dólares en nuevos compromisos de préstamo en sus primeros 15 meses, y 10 años en Silicon Valley Bank en roles de relaciones y crédito.
La empresa enmarcó la contratación como un paso para fortalecer el financiamiento de ciencias de la vida y buscar nuevas oportunidades en Medtech, Healthtech, Biotech y Diagnostics/Tools.
Trinity Capital (Nasdaq: TRIN) 사장은 덴버에 본사를 두고 2025년 10월 8일부로 Life Sciences 부문 Managing Director로 Paul D'Agrosa를 임명했습니다.
Mr. D'Agrosa는 미국 내 새로운 시장에서 Trinity의 Life Sciences 플랫폼을 확장하는 데 기여하기 위해 합류하며, 대출 창출, 사업 개발 및 관계 관리 분야에서 10년이 넘는 경험을 보유하고 있습니다. 이전 직책으로는 Horizon Technology Finance의 Managing Director가 있으며, 그곳에서 첫 15개월 안에 새로운 대출 약정에서 1억 4천만 달러 이상을 창출하는 데 기여했고, 실리콘밸리 은행에서 10년간 관계 및 신용 직무를 수행했습니다.
회사는 이 채용을 Life Sciences 대출 강화를 위한 한 걸음으로 설명하며 Medtech, Healthtech, Biotech, Diagnostics/Tools 전반의 새로운 기회 창출을 목표로 하고 있습니다.
Trinity Capital (Nasdaq: TRIN) a nommé Paul D'Agrosa comme Managing Director des Sciences de la Vie, basé à Denver, à compter du 8 octobre 2025.
M. D'Agrosa rejoint l'entreprise pour développer la plateforme des Sciences de la Vie de Trinity sur de nouveaux marchés américains; il apporte plus d'une décennie d'expérience en origination de prêts, développement commercial et gestion des relations. Ses postes précédents incluent Managing Director chez Horizon Technology Finance, où il a contribué à originer plus de 140 millions de dollars de nouveaux engagements de prêts au cours de ses 15 premiers mois, et 10 ans à Silicon Valley Bank dans des rôles liés aux relations et au crédit.
L'entreprise a qualifié cette embauche de étape pour renforcer le financement des sciences de la vie et pour sourcer de nouvelles opportunités dans le Medtech, Healthtech, Biotech et Diagnostics/Outils.
Trinity Capital (Nasdaq: TRIN) hat Paul D'Agrosa zum Managing Director der Life Sciences ernannt, mit Sitz in Denver, wirksam ab dem 8. Oktober 2025.
Herr D'Agrosa verstärkt das Team, um die Life-Sciences-Plattform von Trinity zu erweitern auf neuen US‑Märkten; er bringt mehr als ein Jahrzehnt Erfahrung in der Kreditvergabe, Geschäftsentwicklung und Beziehungsmanagement mit. Zuvor war er Managing Director bei Horizon Technology Finance, wo er in den ersten 15 Monaten mehr als 140 Millionen US-Dollar an neuen Kreditverpflichtungen originiert hat, und 10 Jahre lang in Relations- und Kreditrollen bei der Silicon Valley Bank tätig war.
Das Unternehmen interpretierte die Einstellung als Schritt zur Stärkung der Finanzierung im Bereich Life Sciences und zur Erschließung neuer Chancen in Medtech, Healthtech, Biotech und Diagnostics/Tools.
Trinity Capital (Nasdaq: TRIN) عيّنت بول داغروس مديراً عاماً للعلوم الحياتية، مقره دنفر، اعتباراً من 8 أكتوبر 2025.
انضم السيد داغروس للمساعدة في توسيع منصة العلوم الحياتية لشركة Trinity عبر أسواق أمريكية جديدة؛ وهو يأتي بخبرة تزيد عن عقد من الزمن في إسناد القروض وتطوير الأعمال وإدارة العلاقات. مناصبه السابقة تشمل المدير العام في Horizon Technology Finance، حيث ساهم في إنشاء أكثر من 140 مليون دولار من الالتزامات القرضية الجديدة خلال أول 15 شهراً له، وخمس سنوات في بنك وادي السيليكون في أدوار العلاقات وائتمان.
وصفت الشركة التعيين بأنه خطوة لتعزيز تمويل العلوم الحياتية وتوجيه فرص جديدة عبر Medtech، Healthtech، Biotech وDiagnostics/Tools.
Trinity Capital (Nasdaq: TRIN) 任命 Paul D'Agrosa 为生命科学事业部的执行董事，总部设在丹佛，任命于2025年10月8日生效。
D'Agrosa先生加入，以帮助< b>扩大 Trinity 的生命科学平台在美国新市场的覆盖；他在贷款发放、业务发展和关系管理方面拥有十多年经验。他的前任职包括 Horizon Technology Finance 的董事总经理，在任期的前15个月内，他帮助产生了超过1.4亿美元的新贷款承诺，并在 Silicon Valley Bank 担任关系与信贷岗位达10年。
公司将此次雇佣视为加强生命科学贷款并在医疗技术、健康科技、生物技术和诊断/工具领域发掘新机会的一步。
- Appointment targets expansion of Life Sciences vertical across U.S. markets
- Over $140M in loan commitments originated by D'Agrosa at Horizon within 15 months
- Adds 10+ years of sector experience including Silicon Valley Bank roles
- New Denver base broadens Trinity's geographic coverage in the Western U.S.
- None.
"We are pleased to welcome Paul to the team," said Rob Lake, Senior Managing Director of Life Sciences at Trinity Capital. "His track record in life sciences lending and network of industry relationships will play an important role as we strengthen and grow our Life Sciences platform."
Prior to Trinity, Mr. D'Agrosa served as Managing Director at Horizon Technology Finance, where he oversaw the
"I'm excited to join Trinty and originate new opportunities for the team," said Mr. D'Agrosa. "Trinity is growing rapidly, and I look forward to helping them support innovative companies that are transforming the industry."
About Trinity Capital Inc.
Trinity Capital Inc. (Nasdaq: TRIN) is an international alternative asset manager that seeks to deliver consistent returns for investors through access to private credit markets. Trinity Capital sources and structures investments in well-capitalized growth-oriented companies across five distinct lending verticals: Sponsor Finance, Equipment Finance, Tech Lending, Asset Based Lending, and Life Sciences. As a long-term, trusted partner for innovative companies seeking tailored debt solutions, Trinity Capital has deployed more than
View original content to download multimedia:https://www.prnewswire.com/news-releases/trinity-capital-inc-expands-life-sciences-vertical-with-appointment-of-paul-dagrosa-302577669.html
SOURCE Trinity Capital Inc.
FAQ
Who is Paul D'Agrosa and what role did Trinity Capital (TRIN) name him to on Oct. 8, 2025?
What experience does Paul D'Agrosa bring to Trinity Capital (TRIN)?
How much lending did Paul D'Agrosa originate at Horizon before joining TRIN?
How will the hire affect Trinity Capital's (TRIN) Life Sciences coverage?
Where will Paul D'Agrosa be based for Trinity Capital (TRIN) and why does location matter?
Does the announcement state any immediate financial guidance or capital commitments for TRIN related to the hire?
